Cargando…

Cytogenetic characterization of the malignant primitive neuroectodermal SK-PN-DW tumor cell line

BACKGROUND: The SK-PN-DW cell line was established in 1979 and is commercially available. Despite the use of this cell line as an in vitro model for functional and therapeutic studies of malignant primitive neuroectodermal tumor (PNET), there is a lack of complete information about the genetic alter...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Na, Bao, Wanguo, Zhang, Kaiyu, Lu, Xianglan, Crew, Rebecca, Wang, Xianfu, Liu, Guangming, Wang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498632/
https://www.ncbi.nlm.nih.gov/pubmed/31046733
http://dx.doi.org/10.1186/s12885-019-5625-1
_version_ 1783415652841684992
author Du, Na
Bao, Wanguo
Zhang, Kaiyu
Lu, Xianglan
Crew, Rebecca
Wang, Xianfu
Liu, Guangming
Wang, Feng
author_facet Du, Na
Bao, Wanguo
Zhang, Kaiyu
Lu, Xianglan
Crew, Rebecca
Wang, Xianfu
Liu, Guangming
Wang, Feng
author_sort Du, Na
collection PubMed
description BACKGROUND: The SK-PN-DW cell line was established in 1979 and is commercially available. Despite the use of this cell line as an in vitro model for functional and therapeutic studies of malignant primitive neuroectodermal tumor (PNET), there is a lack of complete information about the genetic alterations that are present at the cytogenetic level. Thus, the current study aimed to characterize the cytogenetic profile of this cell line. METHODS: Routine G-banded chromosome analysis, fluorescence in situ hybridization, and oligonucleotide array comparative genomic hybridization assays were performed to characterize the chromosomal changes in this cell line. RESULTS: The G-banded karyotype analysis showed that the number of chromosomes in this cell line ranged between 36 and 41. Importantly, all cells displayed a loss of chromosomes Y, 11, 13, and 18. However, some cells showed an additional loss of chromosome 10. Additionally, the observed structural changes indicated: a) unbalanced translocation between chromosomes 1 and 7; b) translocation between chromosomes 11 and 22 at breakpoints 11q24 and 22q12, which is a classical translocation that is associated with Ewing sarcoma; c) a derivative chromosome due to a whole arm translocation between chromosomes 16 and 17 at likely breakpoints 16p10 and 17q10; and d) possible rearrangement in the short arm of chromosome 18. Moreover, a variable number of double minutes were also observed in each metaphase cell. Furthermore, the microarray assay results not only demonstrated genomic-wide chromosomal imbalance in this cell line and precisely placed chromosomal breakpoints on unbalanced, rearranged chromosomes, but also revealed information about subtle chromosomal changes and the chromosomal origin of double minutes. Finally, the fluorescence in situ hybridization assay confirmed the findings of the routine cytogenetic analysis and microarrays. CONCLUSION: The accurate determination of the cytogenetic profile of the SK-PN-DW cell line is helpful in enabling the research community to utilize this cell line for future identity and comparability studies, in addition to demonstrating the utility of the complete cytogenetic profile, as a public resource.
format Online
Article
Text
id pubmed-6498632
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64986322019-05-09 Cytogenetic characterization of the malignant primitive neuroectodermal SK-PN-DW tumor cell line Du, Na Bao, Wanguo Zhang, Kaiyu Lu, Xianglan Crew, Rebecca Wang, Xianfu Liu, Guangming Wang, Feng BMC Cancer Research Article BACKGROUND: The SK-PN-DW cell line was established in 1979 and is commercially available. Despite the use of this cell line as an in vitro model for functional and therapeutic studies of malignant primitive neuroectodermal tumor (PNET), there is a lack of complete information about the genetic alterations that are present at the cytogenetic level. Thus, the current study aimed to characterize the cytogenetic profile of this cell line. METHODS: Routine G-banded chromosome analysis, fluorescence in situ hybridization, and oligonucleotide array comparative genomic hybridization assays were performed to characterize the chromosomal changes in this cell line. RESULTS: The G-banded karyotype analysis showed that the number of chromosomes in this cell line ranged between 36 and 41. Importantly, all cells displayed a loss of chromosomes Y, 11, 13, and 18. However, some cells showed an additional loss of chromosome 10. Additionally, the observed structural changes indicated: a) unbalanced translocation between chromosomes 1 and 7; b) translocation between chromosomes 11 and 22 at breakpoints 11q24 and 22q12, which is a classical translocation that is associated with Ewing sarcoma; c) a derivative chromosome due to a whole arm translocation between chromosomes 16 and 17 at likely breakpoints 16p10 and 17q10; and d) possible rearrangement in the short arm of chromosome 18. Moreover, a variable number of double minutes were also observed in each metaphase cell. Furthermore, the microarray assay results not only demonstrated genomic-wide chromosomal imbalance in this cell line and precisely placed chromosomal breakpoints on unbalanced, rearranged chromosomes, but also revealed information about subtle chromosomal changes and the chromosomal origin of double minutes. Finally, the fluorescence in situ hybridization assay confirmed the findings of the routine cytogenetic analysis and microarrays. CONCLUSION: The accurate determination of the cytogenetic profile of the SK-PN-DW cell line is helpful in enabling the research community to utilize this cell line for future identity and comparability studies, in addition to demonstrating the utility of the complete cytogenetic profile, as a public resource. BioMed Central 2019-05-02 /pmc/articles/PMC6498632/ /pubmed/31046733 http://dx.doi.org/10.1186/s12885-019-5625-1 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Du, Na
Bao, Wanguo
Zhang, Kaiyu
Lu, Xianglan
Crew, Rebecca
Wang, Xianfu
Liu, Guangming
Wang, Feng
Cytogenetic characterization of the malignant primitive neuroectodermal SK-PN-DW tumor cell line
title Cytogenetic characterization of the malignant primitive neuroectodermal SK-PN-DW tumor cell line
title_full Cytogenetic characterization of the malignant primitive neuroectodermal SK-PN-DW tumor cell line
title_fullStr Cytogenetic characterization of the malignant primitive neuroectodermal SK-PN-DW tumor cell line
title_full_unstemmed Cytogenetic characterization of the malignant primitive neuroectodermal SK-PN-DW tumor cell line
title_short Cytogenetic characterization of the malignant primitive neuroectodermal SK-PN-DW tumor cell line
title_sort cytogenetic characterization of the malignant primitive neuroectodermal sk-pn-dw tumor cell line
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498632/
https://www.ncbi.nlm.nih.gov/pubmed/31046733
http://dx.doi.org/10.1186/s12885-019-5625-1
work_keys_str_mv AT duna cytogeneticcharacterizationofthemalignantprimitiveneuroectodermalskpndwtumorcellline
AT baowanguo cytogeneticcharacterizationofthemalignantprimitiveneuroectodermalskpndwtumorcellline
AT zhangkaiyu cytogeneticcharacterizationofthemalignantprimitiveneuroectodermalskpndwtumorcellline
AT luxianglan cytogeneticcharacterizationofthemalignantprimitiveneuroectodermalskpndwtumorcellline
AT crewrebecca cytogeneticcharacterizationofthemalignantprimitiveneuroectodermalskpndwtumorcellline
AT wangxianfu cytogeneticcharacterizationofthemalignantprimitiveneuroectodermalskpndwtumorcellline
AT liuguangming cytogeneticcharacterizationofthemalignantprimitiveneuroectodermalskpndwtumorcellline
AT wangfeng cytogeneticcharacterizationofthemalignantprimitiveneuroectodermalskpndwtumorcellline